GENERAL ATLANTIC, L.P. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$3.6T
Holdings
15
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DLODLOCAL | 63,906,695 | $724.7B | 19.97% | |
| 2 | CHYMCHIME | 19,208,760 | $662.9B | 18.26% | |
| 3 | ALHCALIGNMENT HEALTHCARE | 43,993,323 | $615.9B | 16.97% | |
| 4 | XPXP, INC | 25,517,733 | $515.5B | 14.20% | |
| 5 | AKROAKERO THERAPEUTICS | 5,733,989 | $306.0B | 8.43% | |
| 6 | ALKTALKAMI | 9,645,318 | $290.7B | 8.01% | |
| 7 | PHVSPHARVARIS | 7,531,252 | $132.6B | 3.65% | |
| 8 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $127.2B | 3.51% | |
| 9 | BULLWEBULL | 7,148,051 | $85.5B | 2.36% | |
| 10 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $73.8B | 2.03% | |
| 11 | RPRXROYALTY PHARMA | 1,500,000 | $54.0B | 1.49% | |
| 12 | RSKDRISKIFIED | 5,324,998 | $26.6B | 0.73% | |
| 13 | ADAGADAGENE | 3,825,952 | $7.5B | 0.21% | |
| 14 | ALMSALUMIS | 1,297,530 | $3.9B | 0.11% | |
| 15 | GROVGROVE COLLABORATIVE | 2,474,859 | $2.8B | 0.08% |